Eleanor Blalock

Eleanor Blalock is a member of the Health Analytics practice. She currently concentrates on healthcare-related strategy and litigation consulting with a focus on data analysis.

She specializes in leveraging large datasets to gain insight into the opportunities and risks facing healthcare entities. She works with clients across the healthcare industry, including pharmaceutical manufacturers, industry groups, hospitals, pharmacy benefit managers, and insurers.

Ms. Blalock has significant experience assisting clients with aspects of the 340B drug discount program. She has published extensively on issues related to 340B and on pharmaceutical pricing issues generally.